Shares of Nvidia fell on Friday, while rival Advanced Micro Devices rallied after the CEO of Arista Networks said her company is shifting some workloads ... .
AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD) and diabetic retinal disease, including non-proliferative diabetic retinopathy (NPDR).
The U.S. has entered into a trade agreement with Taiwan, with the U.S. cutting tariffs from 20% to 15% and Taiwan pledging to remove 99% of its tariff barriers ... tech firms such as AMD and Nvidia rely on TSMC for manufacturing semiconductor chips ... ....